By B.N. Frank
Earlier this summer, The Food and Drug Administration (FDA) took a lot of heat for approving a $56,000/year Alzheimers Drug that may not even be effective (see 1, 2). Unfortunately, the regulatory agency has a long history of siding with…
FDA Approved Heart Pumps Despite Manufacturing and Quality Problems; 3,000 Death Reports, 20,000 Injury Reports Filed
Share this article
More News
This Will Be Nvidia’s Stock Price by the End of 2027
October 28, 2026
Wall Street analysts target $15 to $30
October 28, 2026
Is PSEG’s Dividend Enough To Make Up For Its Lagging Stock Price?
October 28, 2026